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Genetic tests are now offered internationally, through
both public and private sector genetic testing services.
Physicians prescribing these tests and biologists receiv-
ing the samples need to know which tests are available,
w h e r et h e ya r ep e r f o r m e da nd whether the identified
laboratories meet quality standards. To fulfil this need,
http://www.orpha.net was launched thirteen years ago to
set up a database of clinical laboratories in the field of
rare diseases. Data was collected in 1 country in 1997,
15 in 2003, 26 in 2006 and 38 in 2010. This major effort
was made possible thanks to resources from the EC DG
for Public Health. In collaboration with the EuroGentest
Network of Excellence, information on quality manage-
ment has been added to the Orphanet database over the
past four years. To obtain information on genetic testing
i nO r p h a n e t ,i ti sp o s s i b l et os e a r c hb yd i s e a s en a m eo r
by gene (symbol or name in English) in addition to the
traditional search by name of laboratory or professional.
The information provided on laboratories includes data
on quality management. Currently, 956 laboratories
offering tests for 1,559 genes are registered in the
Orphanet database. The test offer differs greatly from
one large country to another: Germany (1,141 genes),
France (874 genes), Italy (625 genes), Spain (582 genes),
UK (414 genes). Medium and small-sized countries have
a test offer ranging from 1 to 233 genes. This situation
explains the large cross-border flow of specimens and
underlines the need to provide access to services in
other countries when necessary, especially for very rare
diseases. Testing for Cystic fibrosis is the only service
which is provided by every country. The distribution of
this test offer will be presented.
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